Glenmark financials
WebFinancial Results. Q3 FY2024-23. View. Financial Results. Q2 FY2024-23. View. Financial Results. Q1 FY2024-23. View WebFor the first quarter of FY 2024-23, Glenmark’s consolidated revenues from operations was at Rs. 27,773 Mn decrease of -6.3%. Excluding global sales of Covid-related products in the first quarter of FY22, the year-on-year growth of the base business in the current financial year was 10.4%. GLENMARK PHARMACEUTICALS LTD. (GPL)
Glenmark financials
Did you know?
WebGet Glenmark Pharma latest Balance Sheet, Financial Statements and Glenmark Pharma detailed profit and loss accounts. WebApr 11, 2024 · Glenmark Pharma had first explored selling a stake in its API business in 2024 but ultimately opted to spin off and list Glenmark Life Sciences in 2024. Besides to lower its debt, the sale is also necessary as Glenmark Pharma has until August 2024 to cut its stake to 75% to meet Indian regulatory norms on promoter holdings, Mint reported.
WebApr 10, 2024 · Glenmark’s gross debt was ₹ 4,210 crore and net debt at ₹ 2,620 crore as on December 2024 end, it said. Furthermore, Glenmark has brought down its net debt by ₹ 100 crore since September.
Web2 days ago · IndusInd will be utilising the co-finance funding for lending to the agricultural sector in the country. ... Glenmark Pharma is considering selling a majority of its 82% stake in unit Glenmark ... WebGLENMARK fundamentals Overview Statements Statistics Dividends Earnings Revenue Key facts Market capitalization — Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) — Founded — Employees — CEO — Website — Valuation Fundamental metrics to determine fair value of the stock Summary P/E ratio — P/S ratio — Market …
WebCompany Essentials Market Cap ₹ 13,603.33 Cr. Enterprise Value ₹ 17,244.04 Cr. No. of Shares 28.22 Cr. P/E 8.77 P/B 0.76 Face Value ₹ 1 Div. Yield 0.52 % Book Value (TTM) ₹ 638.54 CASH ₹ 29.63 Cr. DEBT ₹ 3,670.35 Cr. Promoter Holding 46.65 % EPS (TTM) ₹ 55 Sales Growth 7.58 % ROE 12.67 % ROCE 13.25 % Profit Growth 21.12 % Add Your Ratio
WebGet the latest Glenmark Pharmaceuticals Ltd (GLENMARK) real-time quote, historical performance, charts, and other financial information to help you make more informed … bapcb nfisWebGet Glenmark Pharma latest Consolidated Balance Sheet, Financial Statements and Glenmark Pharma detailed profit and loss accounts. bapcmWebApr 11, 2024 · GLENMARK’s price/sales is 1.11. Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. bapbo korean restaurantWebGlenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address the unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. bapca 100WebGet the detailed quarterly/annual income statement for Glenmark Pharmaceuticals Limited (GLENMARK.NS). Find out the revenue, expenses and profit or loss over the last fiscal … bapca 80WebApr 11, 2024 · India's Glenmark Pharmaceuticals Ltd is considering selling a majority of the 82% stake it holds in Glenmark Life Sciences Ltd as it looks to lower its debt load, the Mint business daily reported ... bapca500WebGLENMARK PHARM financial statements, including revenue, expenses, profit, and loss. The total revenue of GLENMARK for the last quarter is 34.64B INR, and it's 2.63% … bapcb